TISEO, GIUSY
 Distribuzione geografica
Continente #
NA - Nord America 2.924
AS - Asia 1.596
EU - Europa 974
SA - Sud America 311
AF - Africa 95
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 1
Totale 5.906
Nazione #
US - Stati Uniti d'America 2.847
SG - Singapore 651
CN - Cina 329
IT - Italia 284
HK - Hong Kong 274
BR - Brasile 249
SE - Svezia 181
VN - Vietnam 127
DE - Germania 123
GB - Regno Unito 89
BG - Bulgaria 66
FR - Francia 58
IN - India 55
CA - Canada 39
CI - Costa d'Avorio 36
RU - Federazione Russa 35
FI - Finlandia 30
AR - Argentina 24
TR - Turchia 23
MX - Messico 21
JP - Giappone 20
AT - Austria 19
BD - Bangladesh 17
CZ - Repubblica Ceca 16
IQ - Iraq 15
PK - Pakistan 15
SN - Senegal 15
ZA - Sudafrica 13
SA - Arabia Saudita 12
ES - Italia 11
NL - Olanda 11
VE - Venezuela 11
EC - Ecuador 10
PL - Polonia 10
KR - Corea 8
MA - Marocco 8
AE - Emirati Arabi Uniti 7
CO - Colombia 7
EG - Egitto 7
IE - Irlanda 7
UZ - Uzbekistan 7
CH - Svizzera 6
JO - Giordania 6
UA - Ucraina 6
AZ - Azerbaigian 5
KE - Kenya 5
AU - Australia 4
ID - Indonesia 4
LT - Lituania 4
PE - Perù 4
PH - Filippine 4
TN - Tunisia 4
BE - Belgio 3
DZ - Algeria 3
HN - Honduras 3
NG - Nigeria 3
AL - Albania 2
BB - Barbados 2
CL - Cile 2
DK - Danimarca 2
GR - Grecia 2
GT - Guatemala 2
JM - Giamaica 2
KW - Kuwait 2
MD - Moldavia 2
NP - Nepal 2
PY - Paraguay 2
SK - Slovacchia (Repubblica Slovacca) 2
TT - Trinidad e Tobago 2
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BZ - Belize 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
EE - Estonia 1
EU - Europa 1
GA - Gabon 1
GE - Georgia 1
GY - Guiana 1
HU - Ungheria 1
IL - Israele 1
KH - Cambogia 1
KZ - Kazakistan 1
LK - Sri Lanka 1
MV - Maldive 1
MY - Malesia 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
PR - Porto Rico 1
PS - Palestinian Territory 1
RS - Serbia 1
SI - Slovenia 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TW - Taiwan 1
UY - Uruguay 1
Totale 5.906
Città #
Singapore 397
Ashburn 372
San Jose 304
Hong Kong 272
Santa Clara 243
Chandler 198
Dallas 178
Fairfield 153
Shanghai 111
New York 94
Seattle 76
Woodbridge 69
Sofia 65
Boardman 64
Florence 62
Wilmington 59
Beijing 58
Los Angeles 58
Houston 56
Munich 52
Princeton 48
Cambridge 47
London 41
Lawrence 40
Abidjan 36
Lauterbourg 36
Hanoi 32
Ho Chi Minh City 31
Medford 29
Buffalo 25
Council Bluffs 25
Ogden 25
Boulder 24
Frankfurt am Main 22
São Paulo 20
Tokyo 19
Pisa 18
Redondo Beach 18
Turku 18
Vienna 18
Ann Arbor 17
Chicago 17
Dakar 15
Pune 15
Serra 14
Stockholm 14
Bremen 13
Brno 13
Milan 13
Nuremberg 13
Phoenix 13
Chennai 12
Denver 12
Rome 12
Hefei 11
Istanbul 11
Montreal 11
Brooklyn 10
San Diego 10
Belo Horizonte 9
Helsinki 9
Kent 9
Orem 9
Ottawa 9
Atlanta 8
Düsseldorf 8
Salt Lake City 8
Baghdad 7
Des Moines 7
Dhaka 7
Dong Ket 7
Redwood City 7
Rio de Janeiro 7
Seoul 7
Ankara 6
Brasília 6
Da Nang 6
Dublin 6
Falls Church 6
Fuzhou 6
Hyderabad 6
Johannesburg 6
Lucca 6
Tashkent 6
Toronto 6
Warsaw 6
Amman 5
Amsterdam 5
Baltimore 5
Brandenburg an der Havel 5
Castelfranci 5
Columbus 5
Genoa 5
Haiphong 5
Hải Dương 5
Manchester 5
Poplar 5
Quito 5
Riyadh 5
Bologna 4
Totale 4.018
Nome #
C-C motive chemokine ligand 2 and thromboinflammation in COVID-19-associated pneumonia: A retrospective study 229
Early Use of Remdesivir and Risk of Disease Progression in Hospitalized Patients With Mild to Moderate COVID-19 173
Cefiderocol as rescue therapy for Acinetobacter baumannii and other carbapenem-resistant Gram-Negative infections in ICU patients 170
Early Intra-Abdominal Bacterial Infections after Orthotopic Liver Transplantation: A Narrative Review for Clinicians 161
Corticosteroid Use and Incident Myocardial Infarction in Adults Hospitalized for Community-acquired Pneumonia 149
Antimicrobial consumption and impact of antimicrobial stewardship programmes in long-term care facilities 140
Risk factors and outcomes of endocarditis due to non-HACEK Gram-negative bacilli: data from the prospective multicenter SEI cohort 137
Estimated pulse wave velocity improves risk stratification for all-cause mortality in patients with COVID-19 135
Early alert from the microbiology laboratory improves the outcome of elderly patients with Enterococcus spp. bloodstream infection: Results from a multicentre prospective study 134
Impact of Initial Antifungal Therapy on the Outcome of Patients With Candidemia and Septic Shock Admitted to Medical Wards: A Propensity Score-Adjusted Analysis 129
Time to appropriate antibiotic therapy is a predictor of outcome in patients with bloodstream infection caused by KPC-producing Klebsiella pneumoniae 128
Thyroid cancer and COVID-19: experience at one single thyroid disease referral center 128
Spread of hypervirulent multidrug-resistant ST147 Klebsiella pneumoniae in patients with severe COVID-19: An observational study from Italy, 2020-21 125
Cefiderocol- Compared to Colistin-Based Regimens for the Treatment of Severe Infections Caused by Carbapenem-Resistant Acinetobacter baumannii 125
Efficacy and Safety of Nirmatrelvir/Ritonavir, Molnupiravir, and Remdesivir in a Real-World Cohort of Outpatients with COVID-19 at High Risk of Progression: The PISA Outpatient Clinic Experience 124
Updates in the epidemiology and management of candidemia and Clostridioides difficile coinfection 123
Effect of High-Titer Convalescent Plasma on Progression to Severe Respiratory Failure or Death in Hospitalized Patients with COVID-19 Pneumonia: A Randomized Clinical Trial 123
Comparison of Thrombotic Events and Mortality in Patients with Community-Acquired Pneumonia and COVID-19: A Multicenter Observational Study 123
Efficacy of Bamlanivimab/Etesevimab and Casirivimab/Imdevimab in Preventing Progression to Severe COVID-19 and Role of Variants of Concern 122
JAK inhibition reduces SARS-CoV-2 liver infectivity and modulates inflammatory responses to reduce morbidity and mortality 119
Clinical features and outcomes of bloodstream infections caused by New Delhi metallo-β-lactamase-producing enterobacterales during a regional outbreak 117
Management of COVID patients with convalescent plasma: Do we have the final word? 117
Identifying patients with acute bacterial skin and skin structure infection who need blood cultures 115
Extremely drug-resistant NDM-9-producing ST147 Klebsiella pneumoniae causing infections in Italy, May 2020 112
Elevated MICs of susceptible antipseudomonal cephalosporins in non-carbapenemase-producing, carbapenem-resistant pseudomonas aeruginosa: Implications for dose optimization 112
Cefiderocol for the treatment of metallo-beta-lactamases producing Gram negative bacilli: lights and shadows from the literature 111
Role of Low-Molecular-Weight Heparin in Hospitalized Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Pneumonia: A Prospective Observational Study 110
Characteristics of long-COVID among older adults: a cross-sectional study 107
Ceftolozane/Tazobactam for Treatment of Severe ESBL-Producing Enterobacterales Infections: A Multicenter Nationwide Clinical Experience (CEFTABUSE II Study) 107
Caring for older adults during the COVID-19 pandemic 107
Fatal disseminated Mycobacterium avium infection with bone marrow infiltration and hemophagocytic syndrome 106
Ceftazidime-avibactam use for KPC-Kp infections: a retrospective observational multicenter study 105
Compassionate use of meropenem/vaborbactam for infections caused by KPC-producing Klebsiella pneumoniae: a multicentre study 101
Risk factors for recurrence in patients with Clostridium difficile infection due to 027 and non-027 ribotypes 99
Predictors of intensive care unit admission in patients with Legionella pneumonia: role of the time to appropriate antibiotic therapy 98
Impact of Fluconazole Resistance on the Outcomes of Patients With Candida parapsilosis Bloodstream Infections: A Retrospective Multicenter Study 96
Covid-19 early after renal transplantation: limitations and hazards of unproven therapies. Abstracts of the 20th Biennial European Society for Organ Transplantation (ESOT) Congress 90
Predicting resistant etiology in hospitalized patients with blood cultures positive for Gram-negative bacilli 87
Diagnosis and management of infections caused by multidrug-resistant bacteria: guideline endorsed by the Italian Society of Infection and Tropical Diseases (SIMIT), the Italian Society of Anti-Infective Therapy (SITA), the Italian Group for Antimicrobial Stewardship (GISA), the Italian Association of Clinical Microbiologists (AMCLI) and the Italian Society of Microbiology (SIM) 85
Interplay between Nox2 Activity and Platelet Activation in Patients with Sepsis and Septic Shock: A Prospective Study 84
Role of dalbavancin as combination therapy: evidence from the literature and clinical scenarios 84
Considerations for the optimal management of antibiotic therapy in elderly patients 83
Characteristics of long COVID among older adults: a cross-sectional study 76
null 75
Real-world corticosteroid use in severe pneumonia: a propensity-score-matched study 74
Recrudescence of Plasmodium falciparum malaria 5 years after treatment in an HIV migrant: a case report with a peculiar presentation 72
Prevention of the spread of multidrug-resistant organisms in nursing homes 70
Recurrent Clostridioides difficile infections in solid organ transplant recipients: The international CALIPSO study 70
Interpreting procalcitonin in patients undergoing hemodialysis: a reliable or a misleading marker? 69
What have we learned from the first to the second wave of COVID-19 pandemic? An international survey from the ESCMID Study Group for Infection in the Elderly (ESGIE) group 67
Effectiveness and safety of colistin among older adults: a systematic review and meta-analysis 67
Reply to Epling and Powers, "Cefiderocol and the Need for Higher-Quality Evidence: Methods Matter for Patients" 61
Predictors of survival in elderly patients with coronavirus disease 2019 admitted to the hospital: derivation and validation of the FLAMINCOV score 59
Efficacy of ceftazidime-avibactam plus aztreonam in patients with bloodstream infections caused by MBL- producing Enterobacterales 57
Efficacy of Ceftazidime-avibactam Plus Aztreonam in Patients With Bloodstream Infections Caused by Metallo-β-lactamase-Producing Enterobacterales 39
How I manage patients with New Delhi metallo-beta-lactamase and OXA-48-producing Enterobacterales infections: a practical approach 36
Comparative effectiveness of echinocandins and liposomal amphotericin B for fluconazole-resistant Candida parapsilosis bloodstream infections 28
Persistent candidemia caused by different Candida species: Data from a multicenter contemporary cohort 22
Risk factors for bloodstream infections caused by carbapenem-resistant Acinetobacter baumannii in ICU patients with any site colonisation: A prospective observational study 7
Resistance development to new anti-Gram negatives antibiotics during treatment: geographical epidemiology and risk factors 7
Predictors of mortality and therapeutic efficacy in carbapenem-resistant Acinetobacter baumannii bacteremia 7
Risk factors for Klebsiella spp. infection after solid organ transplantation: a multi-centre, case–control study 5
Risk factors for carbapenem-resistant Acinetobacter baumannii (CRAB) infections in critically ill patients with previous CRAB colonization: a multicentre cohort study 5
Monoclonal antibodies protect against pandrug-resistant Klebsiella pneumoniae 4
Managing skin infections in burn patients: principles and pitfalls 4
The burden of infections caused by Metallo-Beta-Lactamase-Producing Enterobacterales in Italy: epidemiology, outcomes, and management 3
Totale 6.014
Categoria #
all - tutte 21.469
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.469


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022366 9 10 5 6 52 48 42 19 21 11 50 93
2022/2023732 72 78 67 68 67 94 9 61 137 2 71 6
2023/2024395 26 22 42 13 43 90 22 11 12 3 55 56
2024/20251.722 23 67 13 106 153 204 132 58 189 205 208 364
2025/20262.178 130 206 163 176 305 170 336 110 139 263 109 71
2026/202711 11 0 0 0 0 0 0 0 0 0 0 0
Totale 6.014